| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1665539A Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors |
| 09/07/2005 | CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665536A Use of CETP inhibitors and antihypertensive agents as well as optionally HMG COA reductase inhibitors |
| 09/07/2005 | CN1665535A Perylenequinones for use with immunotherapy agents |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665532A Calicheamicin derivative-carrier conjugates |
| 09/07/2005 | CN1665525A Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665515A Methods for treating psychosis associated with interferon-alpha therapy |
| 09/07/2005 | CN1665514A Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells |
| 09/07/2005 | CN1665511A Method of promoting smoking cessation |
| 09/07/2005 | CN1665507A Therapeutic 1, 2, 3, 6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 09/07/2005 | CN1665485A Compositions and methods for amelioration of human female sexual dysfunction |
| 09/07/2005 | CN1665484A Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/07/2005 | CN1665458A Injectable chondrocyte implant |
| 09/07/2005 | CN1665401A Vitamin-containing system for stabilising the immune response of animals |
| 09/07/2005 | CN1663615A Fructose injection of antibiotic medicine |
| 09/07/2005 | CN1663614A 复方氨溴索和头孢菌素类制剂及其应用 Compound ambroxol and cephalosporins preparation and its application |
| 09/07/2005 | CN1663603A Applications of tumor-placenta antigen protein and its DNA in tumor treatment |
| 09/07/2005 | CN1663561A Use of rare earth element salt in preparation of insulin beta cell for treating diabetes |
| 09/07/2005 | CN1663556A Externally applied drug/cosmetic for inhibiting alopeia or/and promoting hair regeneration |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217657C Method of improving survival of patients |
| 09/07/2005 | CN1217656C Method and pharmaceutical composition for regulating lipid concentration |
| 09/06/2005 | US6941229 Method of designing agonists and antagonists to EGF receptor family |
| 09/06/2005 | US6939897 Method and composition for inhibiting arteriosclerosis |
| 09/06/2005 | US6939894 Methods for reducing excessive barking of a dog |
| 09/06/2005 | US6939893 side effect reduction of anticarcinogenic agents, by administering irinotecan and/or taxol, with group VI compounds such as seleno-L-methionine |
| 09/06/2005 | US6939884 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof |
| 09/06/2005 | US6939876 Mixture of analgesic and addition reducting compound of a gamma-aminobutyric acid |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia |
| 09/06/2005 | US6939715 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 09/06/2005 | US6939679 NADE binding proteins |
| 09/06/2005 | US6939570 Composition and methods for treating Alzheimer's disease and other amyloidoses |
| 09/06/2005 | US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges |
| 09/06/2005 | US6939562 Collagen/polysaccharide bilayer matrix |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/06/2005 | US6939557 biocompatible therapeutic article comprising, a macromer having polymerized end groups, precipitated human growth hormone, and a molecule or mixture of molecules which preferentially excludes proteins |
| 09/06/2005 | US6939541 Polypeptide for use in the treatment of viral diseases and cancer |
| 09/06/2005 | CA2250395C Eprosartan dihydrate and a process for its production and formulation |
| 09/06/2005 | CA2179778C Deuterised active agents in transdermal application |
| 09/06/2005 | CA2119516C Ointment for wound treatment |
| 09/06/2005 | CA2105652C Reducing wound scarring with antibodies to growth factors |
| 09/01/2005 | WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia |
| 09/01/2005 | WO2005080384A2 Benzimidazole derivative and use as aii receptor antagonist |
| 09/01/2005 | WO2005080338A2 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins |
| 09/01/2005 | WO2005080030A2 Colloid, method of obtaining colloid or its derivatives and applications thereof |
| 09/01/2005 | WO2005079862A1 USE OF RESISTIN ANTISENSE OLIGONUCLEOTIDES AND/OR siRNA MOLECULES IN THE TREATMENT OF RHEUMATOID ARTHRITIS |
| 09/01/2005 | WO2005079851A2 Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| 09/01/2005 | WO2005079850A1 New combinations of an anti emetic agent and an enkephalinase inhibitor |
| 09/01/2005 | WO2005079849A2 Compounds for enhanced cancer therapy |
| 09/01/2005 | WO2005079848A2 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders |
| 09/01/2005 | WO2005079847A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME |
| 09/01/2005 | WO2005079846A1 NUCLEAR TRANSFER PROMOTER FOR Rac PROTEIN AND METHOD OF SCREENING THE SAME |
| 09/01/2005 | WO2005079843A1 Novel liposome |
| 09/01/2005 | WO2005079835A1 Anticancer agent containing bl angiostatin |
| 09/01/2005 | WO2005079807A1 Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists |
| 09/01/2005 | WO2005079806A1 Use of meloxicam for the treatment of respiratory diseases in pigs |
| 09/01/2005 | WO2005079794A1 Pharmaceutical compositions based on anticholinergics and pegsunercept |
| 09/01/2005 | WO2005079784A1 Use of cholinesterase inhibitors for treating vascular depression |
| 09/01/2005 | WO2005079783A1 Medicine capable of inhibiting activation of transcription factor klf5 |
| 09/01/2005 | WO2005079782A1 N-acetylcysteine compositions and methods for the treatment and prevention of endothelial dysfunction |
| 09/01/2005 | WO2005079774A2 Management of ophthalmologic disorders, including macular degeneration |
| 09/01/2005 | WO2005079772A2 Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension |
| 09/01/2005 | WO2005079767A2 Means for modulation of the effects of opioid-like substances |
| 09/01/2005 | WO2005079766A2 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| 09/01/2005 | WO2005079738A1 Antimicrobial formulations and methods of using the same |
| 09/01/2005 | WO2005079736A1 Composition for treating a dermatological inflammatory response and method of preparation thereof |
| 09/01/2005 | WO2005079600A1 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent |
| 09/01/2005 | WO2005079514A2 Preservation of blood vessels for grafting using inhibitors of tnf-alpha |
| 09/01/2005 | WO2005079284A2 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 09/01/2005 | WO2005079210A2 Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria |
| 09/01/2005 | WO2005065639A3 Novel pharmaceutical compositions |
| 09/01/2005 | WO2005037995A3 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy |
| 09/01/2005 | WO2005002506A3 Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites |
| 09/01/2005 | WO2004089353A8 Methods for treatment of parkinson's disease |
| 09/01/2005 | WO2004078133A8 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/01/2005 | WO2004060911A3 Combination therapy with co-stimulatory factors |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/01/2005 | US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 09/01/2005 | US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/01/2005 | US20050192322 Calcium blockers to treat proliferative vitreoretinopathy |
| 09/01/2005 | US20050192320 (2-Carboxamido)(3-amino)thiophene compounds |
| 09/01/2005 | US20050192290 Antihistamine is selected from ceterizine, fexofenadine, loratadine, and desloratadine or together with a stimulant methylphenidate to down regulate neurotrophic factor selected from nerve growth factor (NGF) and CD40, to treat ADHD, anxiety, depression, and autism |
| 09/01/2005 | US20050192274 Combinations of drugs for the treatment of neoplastic disorders |
| 09/01/2005 | US20050192273 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| 09/01/2005 | US20050192270 Using synergistic mixture of serotonin receptor antagonist and noradrenaline reuptake inhiitor; diarrhea, consti[ation, gastrointestinal disorders |
| 09/01/2005 | US20050192262 Steroid derivatives of 5-androstene-, 5-pregnenolone or corresponding saturated derivatives, for example 5-androstene-3beta,7beta,17alpha-triol; interrupting disturbances in Wnt-signaling, such as cell-cycle arrest in G1-phase, and/or providing an angiostatic effect; benign and/or malignant tumors |
| 09/01/2005 | US20050192261 Methods and reagents for the treatment of immunoinflammatory disorders |
| 09/01/2005 | US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders |
| 09/01/2005 | US20050192255 Sustained release composition for cardio-, cerebro- and peripheral vascular diseases of a Vitamin D receptor activators, e.g., paricalcitol, calcitriol, doxercalciferol, and optionally an angiotensin converting enzyme inhibitor, an angiotensin II receptor I blocker, an aldosterone blocker; no side effect |
| 09/01/2005 | US20050192253 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile |
| 09/01/2005 | US20050192247 Method of treating cancers |
| 09/01/2005 | US20050192245 Medicinal composition for treating arteriosclerosis |